chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine, had no reaction.  She told them that she had a problem with apples and they made her stay for an additional 30  minutes, and was feeling okay and they went home.  Then about 3-4 weeks and she woke up one morning, and her mouth was swollen like she had an overdose of Botox all the way around.  Then it seemed like it was moving and half of her lip swelling was gone.  She got on Benadryl right away and then she thought maybe she had eaten something that she was allergic to, had some fruit thinking that maybe it was in a container of fruit as that's reaction she had with applies.  They called the doctor and he wasn't in, but a NP saw her and she gave her a shot of steroids and put her on the steroid dose pack.  It took about 4-5 days and then it started clearing up and it was gone.  Then all of a sudden 3 weeks later her face started swelling up, the jaw area was swelling up and it moved around.  She went to the ER and was given another prescription for the steroid dose pack and was told to take Benadryl.  Then it went away again.  Then it started happening another day, her left eye was closing up completely and the eyebrow went all the way up and was swollen.  For the first month or so it was in her face.  They went to visit some friends in Arizona for a week and she was fine.  Then, she started with her forehead swelling and she thought it may have been he sun, but she does not stay in the sun long as she covers her head, this lasted about 2 days and went away.  Then they went home and she called him again and said that she had the reaction again on her face and her forehead and the top of her head in her hairline.  In between this she saw an allergist and tested her and said that she had no allergy to apples, other fruits and nuts, and informed her that her blood work was fine.  Then again, just recently 4 days ago she then broke into a rash, her forehead was rosy and her chest was red and itching.  She saw her doctor and he gave her another allergist for her to see and referred her then, but has not seen that doctor yet.  The rash seems to be gone at this time, no swelling at this time, but feels terrible. She has had 4-5 outbreaks since the vaccine, and they continue to keep happening, but in different areas every time.   She is okay for today.
Concerned about left hip pain 6 months following initial AVA vac in 1998 with progressive worsening with each vac x 6 until total hip replacement in 10/2006 due to severe osteoarthritis.  He reported he remembers vaccine site redness, a sore arm and burning at the vaccine site, but no other adverse events.  In the summer of 1998 he began to experience intermittent left hip pain without radiating pain or paresthesia. He advised the ships corpsman who advised him he may have tendonitis and to take oral Motrin. He denies any trauma, injury, straining or illness at the time while aboard ship. His job was a sonar tech.  He described this discomfort as a continuous dull ache 2/10 pain scale to the hip alone that lasted from 1-4 days.  His discomfort would reoccur approximately every 6 months without cause, each time being advised by corpsmen-medical it was probably just a strain. He did not associate worsening pain with subsequent AVA vaccinations but did note his discomfort did worsen over the following 2-4 years both in frequency, intensity and duration.
>6 hrs of inconsolability & no improvement w/Acetaminophen; T102-103; resolved by 18 hrs;
being vaccinated on 02/04/2021,and the second was not administered yet.; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 4th February 2021, batch number: H4H34, expiry date: 28th November 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows:  The age at vaccination was not applicable for this report. The pharmacist reported that the patient did not receive second dose of Shingrix till the time of reporting, which led to incomplete course of vaccination. The reported consented to follow up The health care professional gave consent to follow up. The VAERS details were reported for 1st dose.
Patient has right orchitis. Received MMR #2 7-23-2014. Had #1 MMR 1 month earlier.
On day 8, the injection arm started to form raised, hard areas/lines/lumps that are itchy on the skin surface ? though my arm is still somewhat painful deeper inside.
1st dose pfizer vaccine was given to patient on 07/0/2021. We found out on 07/09/2021 that vaccine expiration date was outside the recommended 31 day expiration window. We reached out to pt on 07/10/2021. Pt  will return to the pharmacy on 07/12/2021 to get be revaccinated.
On September 30, 2010, at approximately 2:30PM, the patient came to the Flu Clinic that was being held, for a Seasonal Flu Vaccine. Patient stated that this was his first flu vaccine, he has ever received. Around 4-5 PM, the same day he began complaining of itching, swelling and tightness in mouth and throat, with coughing, nasal congestion and vomiting. Per ER information, patient denied any fever, difficulty breathing, egg allergy or prior flu vaccine. At or about 8:00PM that night, the patient went to Emergency Room, for possible reaction. By 8:36PM, patient stated that symptoms had resolved. I attempted to contact patient, three times and was unable to make contact with him, to question him about any foods he had ingested or any other activity that he may have participated in, to have caused him to have an allergic type reaction. The above information was taken from the ER report.
pt recvd vax 17MAR93 & w/in 30 seconds became weak & limp; immed exp sz & lost of consciousness; approx 1 min later pt became semiconscious but was cold, clammy & vomited; It was felt pt exp anaphylactoid or hysn react;
Pfizer was mixed with less than 1.8ml (but equal or greater than 1.5ml) diluent. The patient received the dose of 0.3ml out of this vial
Vaccine spilled during administration. Vaccine had to be given again to patient on the same day.
vaccine location=Left leg; Extreme muscle aches; Chills; Headache; Shakes; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left leg on 06Apr2021 at 14:00 (at the age of 67-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, heart condition, known allergy to penicillin and COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO), olmesartan (MANUFACTURER UNKNOWN), rosuvastatin calcium (CRESTOR), metoprolol (MANUFACTURER UNKNOWN) and clopidogrel (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 02:00,12 hours after shot, the patient experienced extreme muscle aches, chills, headache, shakes and loss of appetite for about 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events extreme muscle aches, chills, headache, shakes and loss of appetite were recovered on 08Apr2021.   No follow-up attempts are possible. No further information is expected.
As per employee felt nausea, sneezing and nasal discharge. Employee stated discomforts subsided next day.
patient had no signs of complications after birth.    Shortly after receiving hepatitis vaccination by the nurse the baby began experiencing stopped breathing at intervals experiencing apnea and  shortness of breath.  Th e baby is currently in the nic unit of the Huntsville East Women and Childrens Center.   Pt.  has shown an  abnormal CT scan.  Currently awaiting other test results.  5/14/09 newborn admission info and vax info received from hospital of birth. Hep B GSK-AHBVB608AA given at 1525 on 5/11/2009. 7/7/09 D/C summary recd for DOS 5/9-30/2009 with D/C DX:  Term birth.  Suspected sepsis.  Apnea.  Seizures. On day 2 of life infant began having apnea episodes and transferred to NICU. Sepsis w/u (-). Neuro consult dx seizures based on abnormal EEG. Apnea resolved once on phenobarb.
HCP reporting an improperly stored vaccine was administered to a patient.; This spontaneous report has been received from a medical assistant, referring a patient of unknown age and gender. The patient's concurrent conditions, medical history, and concomitant medications were not provided.    On 12-AUG-2022, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular Injection (lot number W002889 has been verified to be a valid lot number, expiration date 06-MAR-2023) (strength, dose, frequency, and anatomical location were not provided) indicated as prophylaxis (product storage error).  The  hepatitis a vaccine, inactivated (VAQTA) vaccine was stored at a temperature of 46.5 Fahrenheit (F) for the ime frame of 1 hour 0 minutes 0 seconds. There was no previous temperature excursion.
Husband states pt. is very fatigued and has had fever of less than 102 F for five days. Pt now has fever over 102 F. Saw a Dr.  Dr. states probably reaction to vaccines.
Pt vaccinated with DTP/OPV developed fever 101.5, local reaction, screaming for more than 3 hrs & hypotonic episode following immunization.
Vaccine prepped on 7/2/2021 and administered on 7/6/2021.  Pt reported no s/s.  Moderna notified of error and recommendation given not to revaccinate.
This spontaneous report was received from a physician and a medical assistant concerning a 17 year old patient of an unknown gender. Concurrent conditions, medical history and allergies were not reported. On 24-MAR-2015, the patient was vaccinated with a dose of GARDASIL (strength, dose, frequency, route and anatomical location were not reported) (lot # K006124, expiration date 02-FEB-2017) that was improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Ongoing joint pain, stiffness, swelling.   I've never had anything like this before.  The symptoms match arthritis. It started in one wrist, then two days later the other wrist.  Then the ball of my feet, then knees.   The severeness has subsided in my feet but wrists and knees continue to be affected.    I've used advil and icing when it flares.  Its been 6 weeks so far of wrist pain and pain in the base of my thumbs.
Tinnitus, bilateral.  No treatment.  Symptoms still present as of 5/12/2021
GENERALIZED ITCHING, RASH ON FACE PATIENT'S PRIMARY PHYSICIAN BELIEVED TO BE SHINGLES
tingling and numbness in body especially lips; numbness in body especially lips; tingling; numbness in body; grogginess; night sweats; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (grogginess), NIGHT SWEATS (night sweats), PARAESTHESIA ORAL (tingling and numbness in body especially lips), HYPOAESTHESIA ORAL (numbness in body especially lips) and PARAESTHESIA (tingling) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced SOMNOLENCE (grogginess) and NIGHT SWEATS (night sweats). On 06-May-2021, the patient experienced PARAESTHESIA ORAL (tingling and numbness in body especially lips), HYPOAESTHESIA ORAL (numbness in body especially lips), PARAESTHESIA (tingling) and HYPOAESTHESIA (numbness in body). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 06-May-2021, SOMNOLENCE (grogginess) and NIGHT SWEATS (night sweats) had resolved. At the time of the report, PARAESTHESIA ORAL (tingling and numbness in body especially lips), HYPOAESTHESIA ORAL (numbness in body especially lips), PARAESTHESIA (tingling) and HYPOAESTHESIA (numbness in body) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was treated with PARACETAMOL (TYLENOL).   This case was linked to MOD-2021-110021 (Patient Link).
flu-like symptoms; was hurting; she had a fever of 101F; she had nausea; throwing up; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (was hurting), PYREXIA (she had a fever of 101F), NAUSEA (she had nausea) and VOMITING (throwing up) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Aug-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (was hurting), PYREXIA (she had a fever of 101F), NAUSEA (she had nausea) and VOMITING (throwing up). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (was hurting), PYREXIA (she had a fever of 101F), NAUSEA (she had nausea) and VOMITING (throwing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported that she is on many concomitant medications but does not remember any names.  No treatment medications were reported.   This case was linked to MOD-2021-314587 (Patient Link).
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In or around 12-SEP-2017, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) for routine health maintenance and for its intended purpose the prevention of shingles. Shortly after receiving the ZOSTAVAX, the patient suffered a right anterior shoulder pain and developed skin lesions in the anterior aspect of his shoulder and was diagnosed with herpes zoster. The patient has continued to suffer from recurrent herpes zoster and later diagnosed with post herpetic neuralgia and chronic pain. The patient has also experienced mental and emotional distress due to resulting physical limitations and the seriousness of his condition. As a result of the ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was considered to be not recovered. Herpes zoster and post herpetic neuralgia were considered disabling. Additional information has been requested.
Headache with associated nausea. Headache and intensity and frequency increased after getting vaccine.  New onset of nausea associated with vaccine. Symptoms come and go.
Localized pain and swelling at site of injection without erythema, pain also restricted down L arm to hand and some paresthesias were noted. Nl new exam.
Day 1 after vaccine- felt fatigued and achy- backaches and chills  Day 2- felt fatigued and achy- backaches Day 3- felt fatigued and achy- backaches, blood in urine; went to family physician, urinalysis and meds given for severe infection  Day 6- started to feel better  Day 11- symptoms started again- back pain, fatigue, chills, body aches Day 13- saw family physician again.  Blood still in urine- no stones found on CAT scan, referred to Urologist. Day 15- Had severe stabbing pain and went to ER, another CAT scan performed- no stones. Blood still in Urine.  Referred to Urologist.    Day 34- symptoms are reoccurring  and waiting for Urologist appointment on 07/07/21
pt recvd vax & 1 yr later the pt devel mumps; No further details were provided;
This case was reported by a other health professional via call center representative and described the occurrence of gastrointestinal disorder in a 39-year-old female patient who received HAVRIX adult (batch number 5D952, expiry date 20th April 2018). Concurrent medical conditions included milk allergy. On 9th August 2016, the patient received the 1st dose of HAVRIX adult .5 ml. On 9th August 2016, 20 min after receiving HAVRIX adult, the patient experienced gastrointestinal disorder. On an unknown date, the outcome of the gastrointestinal disorder was recovered/resolved. It was unknown if the reporter considered the gastrointestinal disorder to be related to HAVRIX adult. Additional details were provided as follows: The healthcare professional reported that the patient stated she had gastrointestinal issues about 20 minutes after receiving HAVRIX. The patient experience same reaction like gastrointestinal issues when she eats or consumes dairy. No other information was provided.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team and product quality group. The reporter is the patient.  A 61-year-old female patient received BNT162b2 (BNT162B2), on 29Mar2021 as dose 1, single (Lot number: ER2613), on 19Apr2021 as dose 2, single (Lot number: EW0158) and on 01Feb2022 as dose 3 (booster), single (Lot number: FJ5683) at the age of 60 years for covid-19 immunisation. The patient's relevant medical history included: "obesity" (unspecified if ongoing), notes: The only thing she has is obesity. There were no concomitant medications.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "got my Pfizer Covid Vaccines and I still got Covid/prescribed Paxlovid". The events "got my pfizer covid vaccines and i still got covid/prescribed paxlovid" required emergency room visit. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Consumer reported regarding Paxlovid. Has taken Paxlovid for two days so far. Has trouble swallowing the tablets. Placing that tablet in honey, holding them in her mouth until they dissolve and then swallowing. Has had the Pfizer shots and the booster shots and still got Covid. Was holding the pills in her mouth for a little while until the size went down a little bit, so the pill was thinner. She would do that, then would take the pills out and then swallow it. She called him and said she went to urgent care.  During the time of Covid when the whole thing happened, she was on unemployment and was not working. When she was working, she was tested every week. Now suddenly, she gets Covid, so she is shocked.
feeling lethargic; not feeling well at all; which she was sick for 4 days with body aches; headache; chills; which she was sick for 4 days with body aches; This spontaneous case was reported by a patient and describes the occurrence of LETHARGY (feeling lethargic), MALAISE (not feeling well at all), ILLNESS (which she was sick for 4 days with body aches), HEADACHE (headache) and CHILLS (chills) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to molds (Mold), Dust allergy (Dust), Pollen allergy (pollen), Allergy to animal dander (pet dander), Allergy (mildew allergy), Perfume sensitivity (perfume), Chemical sensitivity (bleach), Type 1 diabetes mellitus (Start Date: 50 years ago Recent change in status such as improvement or worsening: Stable) and Celiac disease (Recent change in status such as improvement or worsening: Stable) since 2014.    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 22-Apr-2021, the patient experienced LETHARGY (feeling lethargic), MALAISE (not feeling well at all), ILLNESS (which she was sick for 4 days with body aches), HEADACHE (headache), CHILLS (chills) and MYALGIA (which she was sick for 4 days with body aches). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. On 26-Apr-2021, LETHARGY (feeling lethargic), MALAISE (not feeling well at all), ILLNESS (which she was sick for 4 days with body aches), HEADACHE (headache), CHILLS (chills) and MYALGIA (which she was sick for 4 days with body aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Negative.         No concomitant medication was reported.  On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 0.5 milliliter with lot number 016B21A.   This case was linked to MOD-2022-668645, MOD-2022-668640 (Patient Link).
Facial flushing, difficulty swallowing, throat tight. Brought to Emergency Dept.
Few min after receiving HPV and Flu vax - he complained of nausea, feeling weak and cold. While seated lips looked pale, breathing normal. HR strong but somewhat slow - counted 65-70/min RR. Observation done - HR strong at 70/min. Continued observation 15-20 min and recovered.
I had my vaccine on 1/5/2021 and the 2 days after I had a lot of pain in my arm and fatigue which are all things I expected and they were over by Saturday 1/9. Now starting today 1/14 the area is red again and is very itchy
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. The patient's relevant medical history, concurrent conditions and concomitant medications were not reported. On an unknown date in 2014, the patient was inoculated with ZOSTAVAX by a physician for routine health maintenance and prevention of shingles (strength, dose, route of administration, lot # and expiry date were not reported). On an unknown date, the patient was diagnosed with shingles (herpes zoster) despite of vaccinating with ZOSTAVAX. On an unknown date in 2016, the patient was treated by a healthcare provider for shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered serious physical, emotional and economical damages as a result of the patient's injuries. The outcome of the events was unknown. Causality assessment was related.
After receiving the Janssen vaccine, patient was admitted to the ED within 8 hours for dyspnea upon exertion and breathing.  Labs were all within normal limits (CBC, Troponin, CMP, TSH, HCG).  Patient was later discharged for follow up with primary care.